nodes	percent_of_prediction	percent_of_DWPC	metapath
Methoxsalen—CYP1A1—head and neck cancer	0.659	1	CbGaD
Methoxsalen—CYP2A6—Fluorouracil—head and neck cancer	0.0928	0.581	CbGbCtD
Methoxsalen—CYP2A13—nose—head and neck cancer	0.0479	0.911	CbGeAlD
Methoxsalen—CYP1A2—Fluorouracil—head and neck cancer	0.0354	0.222	CbGbCtD
Methoxsalen—CYP3A4—Vinblastine—head and neck cancer	0.0172	0.108	CbGbCtD
Methoxsalen—CYP3A4—Docetaxel—head and neck cancer	0.0142	0.0888	CbGbCtD
Methoxsalen—Device related infection—Fluorouracil—head and neck cancer	0.00753	0.0941	CcSEcCtD
Methoxsalen—CYP2A13—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.00677	0.139	CbGpPWpGaD
Methoxsalen—Lupus erythematosus—Hydroxyurea—head and neck cancer	0.00487	0.0608	CcSEcCtD
Methoxsalen—Systemic lupus erythematosus—Hydroxyurea—head and neck cancer	0.00328	0.0409	CcSEcCtD
Methoxsalen—Skin hyperpigmentation—Hydroxyurea—head and neck cancer	0.00305	0.0381	CcSEcCtD
Methoxsalen—CYP2A13—Xenobiotics—CYP1A1—head and neck cancer	0.00277	0.057	CbGpPWpGaD
Methoxsalen—Digestion impaired—Hydroxyurea—head and neck cancer	0.00271	0.0339	CcSEcCtD
Methoxsalen—Lupus erythematosus—Docetaxel—head and neck cancer	0.00253	0.0316	CcSEcCtD
Methoxsalen—Blister—Hydroxyurea—head and neck cancer	0.00252	0.0314	CcSEcCtD
Methoxsalen—Skin hyperpigmentation—Fluorouracil—head and neck cancer	0.00219	0.0274	CcSEcCtD
Methoxsalen—Tenderness—Hydroxyurea—head and neck cancer	0.00208	0.026	CcSEcCtD
Methoxsalen—CYP1A2—Arylamine metabolism—NAT2—head and neck cancer	0.00198	0.0406	CbGpPWpGaD
Methoxsalen—Blister—Fluorouracil—head and neck cancer	0.00181	0.0226	CcSEcCtD
Methoxsalen—Skin exfoliation—Hydroxyurea—head and neck cancer	0.00173	0.0216	CcSEcCtD
Methoxsalen—Systemic lupus erythematosus—Docetaxel—head and neck cancer	0.0017	0.0213	CcSEcCtD
Methoxsalen—Skin hyperpigmentation—Docetaxel—head and neck cancer	0.00158	0.0198	CcSEcCtD
Methoxsalen—Tenderness—Fluorouracil—head and neck cancer	0.0015	0.0187	CcSEcCtD
Methoxsalen—CYP2A13—Tryptophan metabolism—CYP1A1—head and neck cancer	0.00142	0.0293	CbGpPWpGaD
Methoxsalen—Herpes simplex—Fluorouracil—head and neck cancer	0.00142	0.0177	CcSEcCtD
Methoxsalen—CYP2A6—Fluoropyrimidine Activity—XRCC3—head and neck cancer	0.0014	0.0289	CbGpPWpGaD
Methoxsalen—Redness—Docetaxel—head and neck cancer	0.0014	0.0174	CcSEcCtD
Methoxsalen—Dermatitis bullous—Hydroxyurea—head and neck cancer	0.00138	0.0172	CcSEcCtD
Methoxsalen—Inflammation—Fluorouracil—head and neck cancer	0.00135	0.0168	CcSEcCtD
Methoxsalen—CYP2A13—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.00115	0.0237	CbGpPWpGaD
Methoxsalen—CYP2A13—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.00114	0.0234	CbGpPWpGaD
Methoxsalen—Depression—Vinblastine—head and neck cancer	0.00111	0.0139	CcSEcCtD
Methoxsalen—CYP1A1—mouth—head and neck cancer	0.0011	0.021	CbGeAlD
Methoxsalen—CYP2A13—Biological oxidations—NAT2—head and neck cancer	0.00106	0.0218	CbGpPWpGaD
Methoxsalen—CYP2A13—Metapathway biotransformation—NAT2—head and neck cancer	0.00104	0.0215	CbGpPWpGaD
Methoxsalen—Dermatitis bullous—Fluorouracil—head and neck cancer	0.000992	0.0124	CcSEcCtD
Methoxsalen—Inflammation—Docetaxel—head and neck cancer	0.000971	0.0121	CcSEcCtD
Methoxsalen—CYP2A13—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000933	0.0192	CbGpPWpGaD
Methoxsalen—CYP2A6—Fluoropyrimidine Activity—DPYD—head and neck cancer	0.000933	0.0192	CbGpPWpGaD
Methoxsalen—Skin exfoliation—Docetaxel—head and neck cancer	0.0009	0.0112	CcSEcCtD
Methoxsalen—CYP2A6—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000889	0.0183	CbGpPWpGaD
Methoxsalen—Dry skin—Fluorouracil—head and neck cancer	0.000869	0.0109	CcSEcCtD
Methoxsalen—CYP1A2—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.000863	0.0177	CbGpPWpGaD
Methoxsalen—Ill-defined disorder—Vinblastine—head and neck cancer	0.000807	0.0101	CcSEcCtD
Methoxsalen—Erythema—Hydroxyurea—head and neck cancer	0.000793	0.00991	CcSEcCtD
Methoxsalen—Malaise—Vinblastine—head and neck cancer	0.000784	0.0098	CcSEcCtD
Methoxsalen—Vertigo—Vinblastine—head and neck cancer	0.000781	0.00976	CcSEcCtD
Methoxsalen—CYP1A1—parotid gland—head and neck cancer	0.000769	0.0146	CbGeAlD
Methoxsalen—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.000748	0.00934	CcSEcCtD
Methoxsalen—CYP2A6—Xenobiotics—CYP1A1—head and neck cancer	0.000743	0.0153	CbGpPWpGaD
Methoxsalen—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000736	0.00919	CcSEcCtD
Methoxsalen—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.000735	0.0151	CbGpPWpGaD
Methoxsalen—Discomfort—Vinblastine—head and neck cancer	0.000731	0.00914	CcSEcCtD
Methoxsalen—Dermatitis bullous—Docetaxel—head and neck cancer	0.000716	0.00894	CcSEcCtD
Methoxsalen—Malaise—Hydroxyurea—head and neck cancer	0.000715	0.00894	CcSEcCtD
Methoxsalen—CYP2A6—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000715	0.0147	CbGpPWpGaD
Methoxsalen—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.000669	0.0138	CbGpPWpGaD
Methoxsalen—Discomfort—Hydroxyurea—head and neck cancer	0.000667	0.00833	CcSEcCtD
Methoxsalen—CYP3A4—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.000666	0.0137	CbGpPWpGaD
Methoxsalen—CYP2A6—Fluoropyrimidine Activity—SMUG1—head and neck cancer	0.000664	0.0137	CbGpPWpGaD
Methoxsalen—Oedema—Hydroxyurea—head and neck cancer	0.000647	0.00809	CcSEcCtD
Methoxsalen—Infection—Hydroxyurea—head and neck cancer	0.000643	0.00803	CcSEcCtD
Methoxsalen—CYP1A1—epithelium—head and neck cancer	0.000642	0.0122	CbGeAlD
Methoxsalen—CYP1A1—Estrogen metabolism—GSTM1—head and neck cancer	0.000636	0.0131	CbGpPWpGaD
Methoxsalen—Skin disorder—Hydroxyurea—head and neck cancer	0.000629	0.00785	CcSEcCtD
Methoxsalen—Dry skin—Docetaxel—head and neck cancer	0.000627	0.00784	CcSEcCtD
Methoxsalen—Arrhythmia—Fluorouracil—head and neck cancer	0.000586	0.00732	CcSEcCtD
Methoxsalen—Feeling abnormal—Vinblastine—head and neck cancer	0.000585	0.00731	CcSEcCtD
Methoxsalen—Erythema—Fluorouracil—head and neck cancer	0.000571	0.00713	CcSEcCtD
Methoxsalen—Dyspepsia—Hydroxyurea—head and neck cancer	0.00057	0.00712	CcSEcCtD
Methoxsalen—CYP1A1—trachea—head and neck cancer	0.000568	0.0108	CbGeAlD
Methoxsalen—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000559	0.00698	CcSEcCtD
Methoxsalen—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000533	0.00666	CcSEcCtD
Methoxsalen—CYP2A6—Fluoropyrimidine Activity—TYMS—head and neck cancer	0.000531	0.0109	CbGpPWpGaD
Methoxsalen—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—head and neck cancer	0.000528	0.0109	CbGpPWpGaD
Methoxsalen—Hypersensitivity—Vinblastine—head and neck cancer	0.000523	0.00653	CcSEcCtD
Methoxsalen—CYP2A13—Biological oxidations—GSTM1—head and neck cancer	0.000523	0.0108	CbGpPWpGaD
Methoxsalen—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—head and neck cancer	0.000516	0.0106	CbGpPWpGaD
Methoxsalen—CYP2A13—Metapathway biotransformation—GSTM1—head and neck cancer	0.000516	0.0106	CbGpPWpGaD
Methoxsalen—Body temperature increased—Hydroxyurea—head and neck cancer	0.000512	0.00639	CcSEcCtD
Methoxsalen—CYP1A2—Estrogen Receptor Pathway—CYP1A1—head and neck cancer	0.000498	0.0103	CbGpPWpGaD
Methoxsalen—CYP2A13—Biological oxidations—CYP1A1—head and neck cancer	0.000496	0.0102	CbGpPWpGaD
Methoxsalen—CYP2A13—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000489	0.0101	CbGpPWpGaD
Methoxsalen—Discomfort—Fluorouracil—head and neck cancer	0.00048	0.006	CcSEcCtD
Methoxsalen—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000477	0.00596	CcSEcCtD
Methoxsalen—Dizziness—Vinblastine—head and neck cancer	0.000469	0.00586	CcSEcCtD
Methoxsalen—Oedema—Fluorouracil—head and neck cancer	0.000466	0.00582	CcSEcCtD
Methoxsalen—Infection—Fluorouracil—head and neck cancer	0.000463	0.00578	CcSEcCtD
Methoxsalen—CYP1A2—thyroid gland—head and neck cancer	0.000455	0.00867	CbGeAlD
Methoxsalen—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000451	0.00928	CbGpPWpGaD
Methoxsalen—CYP1A1—thyroid gland—head and neck cancer	0.000449	0.00855	CbGeAlD
Methoxsalen—Headache—Vinblastine—head and neck cancer	0.000445	0.00556	CcSEcCtD
Methoxsalen—CYP2A13—Metabolism—UROD—head and neck cancer	0.000436	0.00896	CbGpPWpGaD
Methoxsalen—Hypotension—Fluorouracil—head and neck cancer	0.000435	0.00544	CcSEcCtD
Methoxsalen—Dizziness—Hydroxyurea—head and neck cancer	0.000428	0.00535	CcSEcCtD
Methoxsalen—CYP1A1—Oxidative Stress—SOD2—head and neck cancer	0.000424	0.00872	CbGpPWpGaD
Methoxsalen—Arrhythmia—Docetaxel—head and neck cancer	0.000423	0.00528	CcSEcCtD
Methoxsalen—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000422	0.00868	CbGpPWpGaD
Methoxsalen—Nausea—Vinblastine—head and neck cancer	0.000421	0.00527	CcSEcCtD
Methoxsalen—Insomnia—Fluorouracil—head and neck cancer	0.000421	0.00526	CcSEcCtD
Methoxsalen—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—head and neck cancer	0.000416	0.00856	CbGpPWpGaD
Methoxsalen—Erythema—Docetaxel—head and neck cancer	0.000412	0.00515	CcSEcCtD
Methoxsalen—Dyspepsia—Fluorouracil—head and neck cancer	0.00041	0.00512	CcSEcCtD
Methoxsalen—Rash—Hydroxyurea—head and neck cancer	0.000408	0.0051	CcSEcCtD
Methoxsalen—Dermatitis—Hydroxyurea—head and neck cancer	0.000408	0.00509	CcSEcCtD
Methoxsalen—Headache—Hydroxyurea—head and neck cancer	0.000405	0.00507	CcSEcCtD
Methoxsalen—CYP1A2—Estrogen metabolism—GSTM1—head and neck cancer	0.000405	0.00833	CbGpPWpGaD
Methoxsalen—CYP1A1—Oxidative Stress—GPX1—head and neck cancer	0.000404	0.00832	CbGpPWpGaD
Methoxsalen—Dysgeusia—Docetaxel—head and neck cancer	0.000403	0.00504	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000402	0.00503	CcSEcCtD
Methoxsalen—CYP1A1—head—head and neck cancer	0.000399	0.00759	CbGeAlD
Methoxsalen—Muscle spasms—Docetaxel—head and neck cancer	0.000396	0.00495	CcSEcCtD
Methoxsalen—Nausea—Hydroxyurea—head and neck cancer	0.000384	0.0048	CcSEcCtD
Methoxsalen—CYP1A2—Estrogen metabolism—CYP1A1—head and neck cancer	0.000384	0.0079	CbGpPWpGaD
Methoxsalen—Feeling abnormal—Fluorouracil—head and neck cancer	0.000384	0.0048	CcSEcCtD
Methoxsalen—Urticaria—Fluorouracil—head and neck cancer	0.00037	0.00462	CcSEcCtD
Methoxsalen—Body temperature increased—Fluorouracil—head and neck cancer	0.000368	0.0046	CcSEcCtD
Methoxsalen—CYP1A1—Estrogen Receptor Pathway—STAT3—head and neck cancer	0.000363	0.00746	CbGpPWpGaD
Methoxsalen—CYP1A2—Xenobiotics—CYP1A1—head and neck cancer	0.000353	0.00726	CbGpPWpGaD
Methoxsalen—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000348	0.00716	CbGpPWpGaD
Methoxsalen—Hypersensitivity—Fluorouracil—head and neck cancer	0.000343	0.00429	CcSEcCtD
Methoxsalen—CYP1A2—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00034	0.00698	CbGpPWpGaD
Methoxsalen—Oedema—Docetaxel—head and neck cancer	0.000336	0.0042	CcSEcCtD
Methoxsalen—Infection—Docetaxel—head and neck cancer	0.000334	0.00417	CcSEcCtD
Methoxsalen—Pruritus—Fluorouracil—head and neck cancer	0.00033	0.00412	CcSEcCtD
Methoxsalen—Skin disorder—Docetaxel—head and neck cancer	0.000327	0.00408	CcSEcCtD
Methoxsalen—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000326	0.0067	CbGpPWpGaD
Methoxsalen—Hypotension—Docetaxel—head and neck cancer	0.000314	0.00393	CcSEcCtD
Methoxsalen—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.000313	0.00643	CbGpPWpGaD
Methoxsalen—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000309	0.00635	CbGpPWpGaD
Methoxsalen—Dizziness—Fluorouracil—head and neck cancer	0.000308	0.00385	CcSEcCtD
Methoxsalen—CYP2A6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000305	0.00626	CbGpPWpGaD
Methoxsalen—Insomnia—Docetaxel—head and neck cancer	0.000304	0.0038	CcSEcCtD
Methoxsalen—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.000297	0.0061	CbGpPWpGaD
Methoxsalen—Dyspepsia—Docetaxel—head and neck cancer	0.000296	0.0037	CcSEcCtD
Methoxsalen—Rash—Fluorouracil—head and neck cancer	0.000294	0.00367	CcSEcCtD
Methoxsalen—Dermatitis—Fluorouracil—head and neck cancer	0.000293	0.00367	CcSEcCtD
Methoxsalen—Headache—Fluorouracil—head and neck cancer	0.000292	0.00365	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00029	0.00363	CcSEcCtD
Methoxsalen—CYP2A6—Biological oxidations—NAT2—head and neck cancer	0.000284	0.00584	CbGpPWpGaD
Methoxsalen—CYP1A1—lymph node—head and neck cancer	0.000279	0.00531	CbGeAlD
Methoxsalen—Feeling abnormal—Docetaxel—head and neck cancer	0.000277	0.00346	CcSEcCtD
Methoxsalen—Nausea—Fluorouracil—head and neck cancer	0.000277	0.00346	CcSEcCtD
Methoxsalen—CYP2A6—NRF2 pathway—TGFA—head and neck cancer	0.000275	0.00566	CbGpPWpGaD
Methoxsalen—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.000273	0.00561	CbGpPWpGaD
Methoxsalen—CYP1A1—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000269	0.00553	CbGpPWpGaD
Methoxsalen—Body temperature increased—Docetaxel—head and neck cancer	0.000266	0.00332	CcSEcCtD
Methoxsalen—CYP1A2—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000262	0.0054	CbGpPWpGaD
Methoxsalen—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000262	0.00539	CbGpPWpGaD
Methoxsalen—CYP1A1—PPARA activates gene expression—YAP1—head and neck cancer	0.000252	0.00518	CbGpPWpGaD
Methoxsalen—CYP2A6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.00025	0.00515	CbGpPWpGaD
Methoxsalen—Hypersensitivity—Docetaxel—head and neck cancer	0.000248	0.0031	CcSEcCtD
Methoxsalen—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—YAP1—head and neck cancer	0.000246	0.00507	CbGpPWpGaD
Methoxsalen—Pruritus—Docetaxel—head and neck cancer	0.000238	0.00297	CcSEcCtD
Methoxsalen—CYP1A2—Estrogen Receptor Pathway—STAT3—head and neck cancer	0.000231	0.00475	CbGpPWpGaD
Methoxsalen—CYP1A2—Phase II conjugation—NAT2—head and neck cancer	0.000231	0.00474	CbGpPWpGaD
Methoxsalen—Dizziness—Docetaxel—head and neck cancer	0.000222	0.00278	CcSEcCtD
Methoxsalen—Rash—Docetaxel—head and neck cancer	0.000212	0.00265	CcSEcCtD
Methoxsalen—Dermatitis—Docetaxel—head and neck cancer	0.000212	0.00265	CcSEcCtD
Methoxsalen—CYP1A1—Biological oxidations—NAT2—head and neck cancer	0.000212	0.00435	CbGpPWpGaD
Methoxsalen—Headache—Docetaxel—head and neck cancer	0.000211	0.00263	CcSEcCtD
Methoxsalen—CYP1A1—Metapathway biotransformation—NAT2—head and neck cancer	0.000209	0.00429	CbGpPWpGaD
Methoxsalen—Nausea—Docetaxel—head and neck cancer	0.0002	0.0025	CcSEcCtD
Methoxsalen—CYP1A2—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000181	0.00373	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	0.000181	0.00373	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	0.000181	0.00373	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—NAT2—head and neck cancer	0.000181	0.00372	CbGpPWpGaD
Methoxsalen—CYP2A6—Fluoropyrimidine Activity—TP53—head and neck cancer	0.000176	0.00362	CbGpPWpGaD
Methoxsalen—CYP1A2—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000171	0.00352	CbGpPWpGaD
Methoxsalen—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—YAP1—head and neck cancer	0.00017	0.00349	CbGpPWpGaD
Methoxsalen—CYP1A2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.00017	0.00349	CbGpPWpGaD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	0.000169	0.00348	CbGpPWpGaD
Methoxsalen—CYP2A6—NRF2 pathway—GSTM1—head and neck cancer	0.00016	0.00329	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—DPYD—head and neck cancer	0.000159	0.00326	CbGpPWpGaD
Methoxsalen—CYP1A1—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000158	0.00325	CbGpPWpGaD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	0.000157	0.00322	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—YAP1—head and neck cancer	0.000151	0.0031	CbGpPWpGaD
Methoxsalen—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000147	0.00302	CbGpPWpGaD
Methoxsalen—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000145	0.00298	CbGpPWpGaD
Methoxsalen—CYP2A6—Biological oxidations—GSTM1—head and neck cancer	0.00014	0.00288	CbGpPWpGaD
Methoxsalen—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.00014	0.00288	CbGpPWpGaD
Methoxsalen—CYP1A2—Biological oxidations—NAT2—head and neck cancer	0.000135	0.00277	CbGpPWpGaD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	0.000133	0.00274	CbGpPWpGaD
Methoxsalen—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	0.000133	0.00274	CbGpPWpGaD
Methoxsalen—CYP2A6—Biological oxidations—CYP1A1—head and neck cancer	0.000133	0.00273	CbGpPWpGaD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	0.00012	0.00247	CbGpPWpGaD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	0.00012	0.00247	CbGpPWpGaD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	0.00012	0.00247	CbGpPWpGaD
Methoxsalen—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000119	0.00244	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—UROD—head and neck cancer	0.000117	0.0024	CbGpPWpGaD
Methoxsalen—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	0.000114	0.00234	CbGpPWpGaD
Methoxsalen—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000113	0.00233	CbGpPWpGaD
Methoxsalen—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000112	0.0023	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	0.000108	0.00222	CbGpPWpGaD
Methoxsalen—CYP1A1—Biological oxidations—GSTM1—head and neck cancer	0.000104	0.00215	CbGpPWpGaD
Methoxsalen—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.000104	0.00214	CbGpPWpGaD
Methoxsalen—CYP1A1—Metapathway biotransformation—GSTM1—head and neck cancer	0.000103	0.00212	CbGpPWpGaD
Methoxsalen—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000103	0.00211	CbGpPWpGaD
Methoxsalen—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000101	0.00208	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	0.0001	0.00206	CbGpPWpGaD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	9.63e-05	0.00198	CbGpPWpGaD
Methoxsalen—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	9.17e-05	0.00189	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—TYMS—head and neck cancer	9.04e-05	0.00186	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—GSTM1—head and neck cancer	8.94e-05	0.00184	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—UROD—head and neck cancer	8.71e-05	0.00179	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—GPX1—head and neck cancer	8.56e-05	0.00176	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	8.5e-05	0.00175	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—CYP1A1—head and neck cancer	8.47e-05	0.00174	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	7.65e-05	0.00157	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	7.65e-05	0.00157	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	7.65e-05	0.00157	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	6.76e-05	0.00139	CbGpPWpGaD
Methoxsalen—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	6.66e-05	0.00137	CbGpPWpGaD
Methoxsalen—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	6.57e-05	0.00135	CbGpPWpGaD
Methoxsalen—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	6.31e-05	0.0013	CbGpPWpGaD
Methoxsalen—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	6.23e-05	0.00128	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	6.14e-05	0.00126	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—UROD—head and neck cancer	5.55e-05	0.00114	CbGpPWpGaD
Methoxsalen—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	5.14e-05	0.00106	CbGpPWpGaD
Methoxsalen—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	5.07e-05	0.00104	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—PTGS2—head and neck cancer	5.04e-05	0.00104	CbGpPWpGaD
Methoxsalen—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	4.87e-05	0.001	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—NAT2—head and neck cancer	4.86e-05	0.000998	CbGpPWpGaD
Methoxsalen—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	4.81e-05	0.000989	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—PTEN—head and neck cancer	4.39e-05	0.000904	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	4.31e-05	0.000886	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—UROD—head and neck cancer	4.29e-05	0.000882	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—DPYD—head and neck cancer	4.26e-05	0.000876	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—YAP1—head and neck cancer	4.04e-05	0.000831	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	3.84e-05	0.00079	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—NAT2—head and neck cancer	3.62e-05	0.000744	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—DPYD—head and neck cancer	3.17e-05	0.000652	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—PIK3CA—head and neck cancer	3.1e-05	0.000638	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—YAP1—head and neck cancer	3.01e-05	0.000619	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—AKT1—head and neck cancer	2.53e-05	0.000521	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.45e-05	0.000504	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—TYMS—head and neck cancer	2.43e-05	0.000499	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.42e-05	0.000499	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—GSTM1—head and neck cancer	2.4e-05	0.000493	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—NAT2—head and neck cancer	2.31e-05	0.000474	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—GPX1—head and neck cancer	2.3e-05	0.000472	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—CYP1A1—head and neck cancer	2.27e-05	0.000468	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.26e-05	0.000465	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—DPYD—head and neck cancer	2.02e-05	0.000416	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.97e-05	0.000406	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—YAP1—head and neck cancer	1.92e-05	0.000395	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—TYMS—head and neck cancer	1.81e-05	0.000372	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—GSTM1—head and neck cancer	1.79e-05	0.000367	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—NAT2—head and neck cancer	1.78e-05	0.000366	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—GPX1—head and neck cancer	1.71e-05	0.000352	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—DPYD—head and neck cancer	1.56e-05	0.000321	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—YAP1—head and neck cancer	1.48e-05	0.000305	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.44e-05	0.000297	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.39e-05	0.000286	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—PTGS2—head and neck cancer	1.35e-05	0.000278	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.26e-05	0.000259	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—PTEN—head and neck cancer	1.18e-05	0.000242	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—TYMS—head and neck cancer	1.15e-05	0.000237	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—GSTM1—head and neck cancer	1.14e-05	0.000234	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—GPX1—head and neck cancer	1.09e-05	0.000224	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—CYP1A1—head and neck cancer	1.08e-05	0.000222	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—PTGS2—head and neck cancer	1.01e-05	0.000207	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—TYMS—head and neck cancer	8.89e-06	0.000183	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	8.87e-06	0.000182	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—GSTM1—head and neck cancer	8.79e-06	0.000181	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—PTEN—head and neck cancer	8.78e-06	0.000181	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—GPX1—head and neck cancer	8.42e-06	0.000173	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—CYP1A1—head and neck cancer	8.33e-06	0.000171	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—PIK3CA—head and neck cancer	8.32e-06	0.000171	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—AKT1—head and neck cancer	6.79e-06	0.00014	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—PTGS2—head and neck cancer	6.42e-06	0.000132	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—PIK3CA—head and neck cancer	6.2e-06	0.000127	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—PTEN—head and neck cancer	5.6e-06	0.000115	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—AKT1—head and neck cancer	5.06e-06	0.000104	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—PTGS2—head and neck cancer	4.96e-06	0.000102	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—PTEN—head and neck cancer	4.32e-06	8.89e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—PIK3CA—head and neck cancer	3.95e-06	8.13e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—AKT1—head and neck cancer	3.23e-06	6.64e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—PIK3CA—head and neck cancer	3.05e-06	6.27e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—AKT1—head and neck cancer	2.49e-06	5.12e-05	CbGpPWpGaD
